A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating Glycolipids

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Journal of the American Chemical Society (Impact Factor: 11.44). 03/2011; 133(14):5198-201. DOI: 10.1021/ja200070u
Source: PubMed

ABSTRACT Structural variants of α-galactosylceramide (αGC) that activate invariant natural killer T cells (iNKT cells) are being developed as potential immunomodulatory agents for a variety of applications. Identification of specific forms of these glycolipids that bias responses to favor production of proinflammatory vs anti-inflammatory cytokines is central to current efforts, but this goal has been hampered by the lack of in vitro screening assays that reliably predict the in vivo biological activity of these compounds. Here we describe a fluorescence-based assay to identify functionally distinct αGC analogues. Our assay is based on recent findings showing that presentation of glycolipid antigens by CD1d molecules localized to plasma membrane detergent-resistant microdomains (lipid rafts) is correlated with induction of interferon-γ secretion and Th1-biased cytokine responses. Using an assay that measures lipid raft residency of CD1d molecules loaded with αGC, we screened a library of ∼200 synthetic αGC analogues and identified 19 agonists with potential Th1-biasing activity. Analysis of a subset of these novel candidate Th1 type agonists in vivo in mice confirmed their ability to induce systemic cytokine responses consistent with a Th1 type bias. These results demonstrate the predictive value of this novel in vitro assay for assessing the in vivo functionality of glycolipid agonists and provide the basis for a relatively simple high-throughput assay for identification and functional classification of iNKT cell activating glycolipids.


Available from: Pooja Arora, Jun 12, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glycolipids play an important role in many biological processes and to this end, synthetic chemists have developed a variety of new techniques and "chemical tools" that allow for the study of glycolipids in vitro and in vivo. The types of probes prepared include fluorescent, radio-labelled, biotinylated and photoreactive ones, as well as others based on liposomes, microarrays and other supramolecular constructs-each of which offers its own advantages, as is discussed. A number of more specialised probes, such as metabolically engineered glycolipids and photopolymerisable glycolipids, have also been prepared in order to investigate various processes including substrate specificities and binding interactions. The purpose of this review is to present the key approaches that can be used for the development of glycolipid probes, organised according to application, and also to discuss the limitations of such strategies, which include the nontrivial task of ensuring that the probe does not adversely influence the biological activity of the parent compound. On the whole, it is exciting to see what can be achieved through the development of chemical probes as tools to study biological processes, and it is envisioned that the reader will be inspired by the large number of superb studies highlighted here and will be encouraged to undertake further work in this research area.
    ChemBioChem 10/2013; 44(40). DOI:10.1002/cbic.201300064 · 3.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introduction of an exo-methylene group into the C-glycoside analogue of KRN7000 was found to afford a new glycosphingolipid ligand with potent agonistic activity for both human and mouse invariant natural killer T lymphocytes. The key synthetic strategy utilized the Nozaki-Hiyama-Kishi reaction to achieve a high-yield coupling between an α-galactosyl aldehyde and a vinyl iodide.
    ChemBioChem 08/2012; 13(12):1733-7. DOI:10.1002/cbic.201200374 · 3.06 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The critical role of peptide antigen-specific T cells in controlling mycobacterial infections is well documented in natural resistance and vaccine-induced immunity against Mycobacterium tuberculosis. However, many other populations of leukocytes contribute to innate and adaptive immunity against mycobacteria. Among these, non-conventional T cells recognizing lipid antigens presented by the CD1 antigen presentation system have attracted particular interest. In this chapter, we review the basic immunobiology and potential antimycobacterial properties of a subset of CD1-restricted T cells that have come to be known as Natural Killer T cells. This group of lipid reactive T cells is notable for its high level of conservation between humans and mice, thus enabling a wide range of highly informative studies in mouse models. As reviewed below, NKT cells appear to have subtle but potentially significant activities in the host response to mycobacteria. Importantly, they also provide a framework for investigations into other types of lipid antigen-specific T cells that may be more abundant in larger mammals such as humans.
    Advances in Experimental Medicine and Biology 01/2013; 783:199-223. DOI:10.1007/978-1-4614-6111-1_11 · 2.01 Impact Factor